SMRTS Series Webinar: Experimental Design and Reporting (Dr. Manoj Lalu)

SMRTS Series Webinar: Experimental Design and Reporting (Dr. Manoj Lalu)

By BioCanRx - Canada's Immunotherapy Network

Date and time

Tuesday, May 8, 2018 · 1 - 2pm EDT

Location

Webinar

https://bluejeans.com/313967043 Meeting ID: 313 967 043 Call in:+1.416.900.2956

Description

Description:

The National Institutes of Health (NIH) have identified two themes underlying the ‘reproducibility crisis’ in bench work and the high rates of failed ‘bench-to-beside’ translation of preclinical research:1) a lack of training in research design; and 2) deficiencies in the reporting of research. To address these issues, new guidelines have been developed and are being implemented by funding agencies, universities, publishers and journals. Dr. Manoj Lalu will present on topics relating to research design, analysis, and reporting of key methodological details. Participants will gain a better understanding of the new guidelines for conducting preclinical research, including the following: 1.Preclinical reporting standards and how to implement them. 2. How to improve the validity of bench studies 3.Generating appropriate sample size calculations for experiments. 4.How to randomize and blind in experiments in a rigorous manner.

About the presenter:

Dr. Lalu is an Associate Scientist appointed to the Ottawa Hospital Research Institute Clinical Epidemiology and Regenerative Medicine Programs. He is also an Assistant Professor (uOttawa) in the Department of Anesthesiology and Pain Medicine and a staff Anesthesiolgist at The Ottawa Hospital. Prior to medical school he completed a B.Sc. (Hons) and Ph.D. in Pharmacology at the University of Alberta. Dr. Lalu's research program focuses on optimizing preclinical to clinical translation - i.e. "bench-to-bedside" via improving methodological rigour and promoting transparent reporting and creating interdisciplinary teams, including patients and other stakeholders.


Hosted by BioCanRx. Please contact Megan Mahoney at memahoney@biocanrx.com for further details.


Sales Ended